$133.96
N/A
Last update: Nov 9, 4:04 PM
Axsome Therapeutics Inc
AXSMNASDAQ
The average analyst price target for Axsome Therapeutics is $236.46, 76.5% above the current price. Of 20 analysts, 20 rate it Buy. Targets range from $153 to $310. The latest change came on Nov 4, 2026, when Mizuho lowered its price target on Axsome Therapeutics from $284 to $272 and kept an Outperform rating.
Price Target Range — 8 Quarters
Analyst Consensus — 20 Analysts
Rating Trend — Last 9 Months
